Verified peer comparison
Crexendo vs Vir Biotechnology Financial Comparison
Direct answer
Crexendo and Vir Biotechnology are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Crexendo email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Crexendo Revenue
- 68,167,000 USD
- Vir Biotechnology Revenue
- 68,556,000 USD
- Crexendo Operating income
- 4,690,000 USD
- Vir Biotechnology Operating income
- -468,020,000 USD